Anti-epidermal growth factor receptor (EGFR) monoclonal antibody combined with cisplatin and 5-fluorouracil in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: a multicentre, open-label, phase II clinical trial.
Annals of oncology : official journal of the European Society for Medical Oncology（2019）
摘要
Combination nimotuzumab-PF chemotherapy demonstrates potential efficacy, and is well tolerated as first-line chemotherapy regimen in recurrent metastatic nasopharyngeal carcinoma.
更多查看译文
关键词
adverse effects,anti-epidermal growth factor receptor monoclonal antibody,chemotherapy,distant metastasis,efficacy,nasopharyngeal carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要